Biotechnology News

October 23, 2012

ARDSLEY, N.Y.--(BUSINESS WIRE)--Acorda Therapeutics, Inc. (Nasdaq: ACOR) today announced that it will host a conference call and live webcast to report its third quarter 2012 financial results on Tuesday, October 30 at 8:30 a.m. ET. To...

October 23, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--AVEO Oncology (NASDAQ: AVEO) today announced that financial results for the company’s third quarter ended September 30, 2012 will be released before the market opens on Tuesday, October 30, 2012. The AVEO...

October 23, 2012

BOSTON--(BUSINESS WIRE)--Highland Instruments, Inc., (“Highland”) today announced IRB approval to initiate a clinical evaluation of Highland’s ElectroSonic Stimulation (“ESStim™”) technology for the treatment of Parkinson’s Disease (“PD”)1. The...

October 23, 2012

SAN DIEGO--(BUSINESS WIRE)--Drug Development Boot Camp

October 23, 2012

BELLEVUE, Wash. & MENLO PARK, Calif.--(BUSINESS WIRE)--Kona Medical has initiated a clinical study of its novel renal denervation therapy. Kona Surround Sound(TM) utilizes externally-delivered therapeutic ultrasound energy to treat...

October 23, 2012

STOCKHOLM--(BUSINESS WIRE)--Regulatory News: BioGaia: (STO:BIOG) 1 January – 30 September 2012 - Net sales reached SEK 572.8 million (232.6). This figure includes licence revenue of SEK 356.0 million from Nestlé that is regarded as non-recurring...

October 22, 2012

CENTER VALLEY, Pa.--(BUSINESS WIRE)--On October 24, 2012, Aesculap Implant Systems will debut the ArcadiusXP L Stand alone Interbody Device for ALIF procedures during the North American Spine Society (NASS) Annual Meeting being held in Dallas,...

October 22, 2012

KANSAS CITY, Mo.--(BUSINESS WIRE)--Taking place November 15, 2012, at the Ritz Charles Convention Center in Overland Park, Kansas, the BioResearch Central Summit is designed to bring together leaders in non-clinical, pre-clinical and clinical...

October 22, 2012

LAKE FOREST, Calif.--(BUSINESS WIRE)--Cryoport, Inc. (OTCBB: CYRX) announced that Jerrell Shelton was elected to its Board of Directors today. Mr. Shelton has served on many public and private boards and currently sits on the Smithsonian...

October 22, 2012

NEW YORK & SAO PAULO--(BUSINESS WIRE)--Forest Laboratories, Inc. (NYSE: FRX), an international pharmaceutical company, and moksha8, a leader in the commercialization of CNS medicines in Latin America, today announced that they have entered...

October 22, 2012

COLUMBIA, Md.--(BUSINESS WIRE)--Osiris Therapeutics, Inc. (NASDAQ: OSIR) announced today it has promoted Lode Debrabandere, Ph.D. to the role of Chief Operating Officer (COO) reporting directly to Chief Executive Officer, C. Randal Mills, Ph.D....

October 22, 2012

REHOVOTH, Israel--(BUSINESS WIRE)--Pharma Two B Ltd., a privately held company focused on developing Fixed-Dose-Combinations (FDCs) of two or more drugs with complementary and synergistic effects, announced that it has completed its second round...

October 22, 2012

PRINCETON, N.J. & PARIS--(BUSINESS WIRE)--STENTYS has announced positive data from the APPOSITION III trial at TCT in Miami. The STENTYS Self-Apposing stent is being assessed in Europe in patients suffering from heart attack (STEMI).

October 22, 2012

ROCKVILLE, Md.--(BUSINESS WIRE)--Sequella Inc., a clinical-stage pharmaceutical company developing novel antibiotics to treat life-threatening infectious diseases, licensed its B-SMART™ technology to Laboratory Corporation of America® Holdings (...

October 22, 2012

HOUSTON--(BUSINESS WIRE)--SpinalCyte, LLC, a spinal technology company focused on autologous regrowth of the spinal disc nucleus using human dermal fibroblasts (HDFs), today announced the addition of Nicholas Theodore, M.D. to its Clinical...

October 22, 2012

GAITHERSBURG, Md.--(BUSINESS WIRE)--GlycoMimetics, Inc., a clinical-stage biotechnology company developing a new class of glycobiology-based therapies for a broad range of indications, announced today that preclinical data related to its lead...

October 22, 2012

BERWYN, Pa.--(BUSINESS WIRE)--After oral treatment, Posiphen totally restored cognitive function in Alzheimer mice. No plaque was detected and the levels of APP/Ab42 and Tau/phospho-Tau returned to normal.

October 22, 2012

VIENNA, Va.--(BUSINESS WIRE)--CEL-SCI Corporation (NYSE MKT: CVM) announced today that an interim review of the safety data from its open label, randomized, controlled, pivotal Phase III study of Multikine (Leukocyte Interleukin, Injection)...

October 22, 2012

CAESAREA, Israel--(BUSINESS WIRE)--Mazor's surgical robotics Renaissance system enters the Japanese market through its distributor, Adachi Medical Instruments

October 22, 2012

ROCKVILLE, Md.--(BUSINESS WIRE)--RegeneRx Biopharmaceuticals, Inc. (OTC Bulletin Board: RGRX) (“the Company” or “RegeneRx”) today announced that it has received $300,000 through the issuance of unsecured convertible notes to two members of...

October 22, 2012

JERUSALEM & LUND, Sweden--(BUSINESS WIRE)--Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) and Active Biotech (NASDAQ OMX NORDIC: ACTI) today announced the presentation of Phase IIa clinical data for investigational laquinimod in moderate to...

October 22, 2012

IRVINE, Calif.--(BUSINESS WIRE)--California Stem Cell, Inc. (CSC)’s Andrew Cornforth, Ph.D. and Robert Dillman, M.D. are scheduled to speak at two prominent immunology conferences this week. The pair will convene with international scientists and...

October 22, 2012

CARLSBAD, Calif.--(BUSINESS WIRE)--GenMark to Show its All-Electronic, Sample-to-Answer Molecular Diagnostics Platform at the Association for Molecular Pathology Meeting

October 22, 2012

BOSTON--(BUSINESS WIRE)--Health Dialog today announced that three of its patient decision aids, designed to lead individuals through a Shared Decision Making process with their doctors, were recognized for excellence at the National Health...

October 22, 2012

LOS ANGELES--(BUSINESS WIRE)--Underwriters for Puma Biotechnology's public offering exercise in full the overallotment option, increasing the total offering to $138 million.

October 22, 2012

MARLBOROUGH, Mass.--(BUSINESS WIRE)--Advanced Cell Technology, Inc. (“ACT”; OTCBB: ACTC), a leader in the field of regenerative medicine, today announced treatment of the fourth patient, the first in the second patient cohort, in its European...

October 22, 2012

SAN DIEGO--(BUSINESS WIRE)--Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) today announced that it will receive a $2 million milestone payment from Merck, known as MSD outside the United States and Canada, under the terms of a development and...

October 22, 2012

NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) today announced its intention to acquire NextWave Pharmaceuticals, a privately held, specialty pharmaceutical company focused on the development and commercialization of unique products for the...

October 22, 2012

BEDMINSTER, N.J.--(BUSINESS WIRE)--NPS Pharmaceuticals, Inc. (NASDAQ: NPSP), a biopharmaceutical company developing innovative therapeutics for rare gastrointestinal and endocrine disorders, today reported data related to the seven patients who...

October 22, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) will host a conference call on Tuesday, November 6, 2012, at 8:30 a.m. ET. During the call, management will provide an update on Infinity's business and discuss the...

October 22, 2012

WILMINGTON, Del.--(BUSINESS WIRE)--Incyte Corporation (Nasdaq:INCY) today announced that Jim Daly has joined Incyte as Executive Vice President and Chief Commercial Officer, reporting to Paul Friedman, M.D., Incyte's President and Chief Executive...

October 22, 2012

FLAGSTAFF, Ariz. & MIAMI--(BUSINESS WIRE)--The FDA has approved the use of the new GORE® Septal Occluder for inclusion in the Gore REDUCE Clinical Study for prevention of recurrent stroke in patent foramen ovale (PFO) patients.

October 22, 2012

GALWAY, Ireland--(BUSINESS WIRE)--Cappella Medical Devices Ltd (Cappella), a medical device company developing dynamic solutions for the treatment of coronary bifurcation disease, today announced the multicenter long term follow up results for...

October 22, 2012

SAN ANTONIO--(BUSINESS WIRE)--eClinicalWorks today announces its Revenue Cycle Management to aid medical practices in optimizing billing. This service is generally available for customers for 2.9% of monthly collected revenue.

October 22, 2012

OTTAWA, Ontario--(BUSINESS WIRE)--Nordion Inc. (TSX: NDN) (NYSE: NDZ) today provided an update regarding proceedings to determine the potential award of costs from Atomic Energy of Canada Limited (AECL) associated with Nordion’s arbitration with...

October 22, 2012

NORTH BILLERICA, Mass.--(BUSINESS WIRE)--Lantheus Medical Imaging, Inc., a global leader in developing, manufacturing and distributing innovative diagnostic imaging agents, today announced that it has extended its contract with Nordion to supply...

October 22, 2012

OTTAWA, Ontario--(BUSINESS WIRE)--Nordion Inc. (TSX: NDN) (NYSE: NDZ) extended its contract with its primary Medical Isotopes customer, Lantheus Medical Imaging, Inc. (LMI) for the supply of Molybdenum-99 (Mo-99). Under the terms of the amended...

October 22, 2012

LEXINGTON, Mass.--(BUSINESS WIRE)--Predictive Biosciences, an innovative developer of molecular diagnostic tests, today announced the publication of the Company’s clinical study for the CertNDx™ Bladder Cancer Assay for Recurrence Monitoring in...

October 22, 2012

LEXINGTON, Mass.--(BUSINESS WIRE)--The USPTO issued a U.S. Patent covering CTP-499, Concert's lead drug candidate under development for the treatment of diabetic nephropathy.

October 22, 2012

RALEIGH, N.C.--(BUSINESS WIRE)--DARA BioSciences launches Soltamox®, first and only liquid version of tamoxifen citrate - an important option for people with breast cancer on tamoxifen therapy.

October 22, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, today announced that management will host a conference call today at 8:00 a.m. ET to discuss its newly formed alliance with...

October 22, 2012

SASSARI, Italy & PRINCETON, N.J.--(BUSINESS WIRE)--ViroStatics announces the first clinical trial to test a new class of anti-HIV medications known as AV-HALTs using the Company’s VS411 has been published in the peer-reviewed journal PLoS ONE...

October 22, 2012

ZURICH & HAMBURG, Germany--(BUSINESS WIRE)--The 18th annual BIO-Europe® international partnering conference will be held in Hamburg, Germany November 12–14, 2012 at the CCH Congress Center Hamburg. Europe’s largest partnering conference...

October 22, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Genzyme announces that they have formed an exclusive alliance to develop and commercialize RNAi therapeutics targeting transthyretin (TTR) for the treatment of transthyretin-mediated amyloidosis

October 22, 2012

LONDON--(BUSINESS WIRE)--22 October 2012 e-Therapeutics plc (AIM: ETX), the drug discovery and development company, today announces its interim results for the six months ended 31 July 2012.

October 22, 2012

PARIS--(BUSINESS WIRE)--The C4C consortium announces the implementation of France's first ever facility for the industrialization of cell therapeutics

October 22, 2012

HYDERABAD, India--(BUSINESS WIRE)--Dr. Reddy’s Laboratories Limited (NYSE:RDY) (“Dr. Reddy’s”), together with its subsidiaries, announces the intended public offer to acquire the issued and outstanding shares of OctoPlus N.V. (Euronext Amsterdam:...

October 20, 2012

TALLAHASSEE, Fla.--(BUSINESS WIRE)--The National Association of Dental Laboratories, the trade association representing the interests of nearly 10,000 dental laboratories in the United States has put forth a legal analysis that indicates that...

October 19, 2012

PARSIPPANY, N.J.--(BUSINESS WIRE)--Precision Spine announced that it will be attending the North American Spine Society (NASS) 27th Annual Meeting in Dallas, Texas during October 24-26, 2012. This event marks the first time Precision Spine will...